Rutsaert S - Search Results

1

Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence.

Lambrechts L, Cole B, Rutsaert S, Trypsteen W, Vandekerckhove L. Lambrechts L, et al. Among authors: rutsaert s. Viruses. 2020 Jan 28;12(2):149. doi: 10.3390/v12020149. Viruses. 2020. PMID: 32012811 Free PMC article. Review.

2

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.

Vibholm L, Schleimann MH, Højen JF, Benfield T, Offersen R, Rasmussen K, Olesen R, Dige A, Agnholt J, Grau J, Buzon M, Wittig B, Lichterfeld M, Petersen AM, Deng X, Abdel-Mohsen M, Pillai SK, Rutsaert S, Trypsteen W, De Spiegelaere W, Vandekerchove L, Østergaard L, Rasmussen TA, Denton PW, Tolstrup M, Søgaard OS. Vibholm L, et al. Among authors: rutsaert s. Clin Infect Dis. 2017 Jun 15;64(12):1686-1695. doi: 10.1093/cid/cix201. Clin Infect Dis. 2017. PMID: 28329286 Free PMC article. Clinical Trial.

3

Digital PCR as a tool to measure HIV persistence.

Rutsaert S, Bosman K, Trypsteen W, Nijhuis M, Vandekerckhove L. Rutsaert S, et al. Retrovirology. 2018 Jan 30;15(1):16. doi: 10.1186/s12977-018-0399-0. Retrovirology. 2018. PMID: 29378600 Free PMC article. Review.

4

Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.

Wijting I, Rutsaert SL, Rokx C, Burger DM, Verbon A, van Kampen J, Boucher C, Rijnders B, Vandekerckhove L. Wijting I, et al. Among authors: rutsaert sl. HIV Med. 2019 Jan;20(1):63-68. doi: 10.1111/hiv.12675. Epub 2018 Sep 30. HIV Med. 2019. PMID: 30270543 Free PMC article. Clinical Trial.

5

In-depth validation of total HIV-1 DNA assays for quantification of various HIV-1 subtypes.

Rutsaert S, De Spiegelaere W, Van Hecke C, De Scheerder MA, Kiselinova M, Vervisch K, Trypsteen W, Vandekerckhove L. Rutsaert S, et al. Sci Rep. 2018 Nov 22;8(1):17274. doi: 10.1038/s41598-018-35403-6. Sci Rep. 2018. PMID: 30467426 Free PMC article.

6

Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.

Morón-López S, Navarro J, Jimenez M, Rutsaert S, Urrea V, Puertas MC, Torrella A, De Clercq L, Ribas BP, Gálvez C, Salgado M, Vandekerckhove L, Blanco J, Crespo M, Martinez-Picado J. Morón-López S, et al. Among authors: rutsaert s. Clin Infect Dis. 2019 Sep 27;69(8):1320-1328. doi: 10.1093/cid/ciy1095. Clin Infect Dis. 2019. PMID: 30590412 Free PMC article. Clinical Trial.

7

In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.

Pannus P, Adams P, Willems E, Heyndrickx L, Florence E, Rutsaert S, De Spiegelaere W, Vandekerckhove L, Seguin-Devaux C, Vanham G. Pannus P, et al. Among authors: rutsaert s. AIDS. 2019 Mar 1;33(3):387-398. doi: 10.1097/QAD.0000000000002068. AIDS. 2019. PMID: 30702513

8

Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors.

Van Hecke C, Trypsteen W, Malatinkova E, De Spiegelaere W, Vervisch K, Rutsaert S, Kinloch-de Loes S, Sips M, Vandekerckhove L. Van Hecke C, et al. Among authors: rutsaert s. EBioMedicine. 2019 Mar;41:443-454. doi: 10.1016/j.ebiom.2019.02.006. Epub 2019 Feb 12. EBioMedicine. 2019. PMID: 30770230 Free PMC article.

9

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study.

Rutsaert S, Steens JM, Gineste P, Cole B, Kint S, Barrett PN, Tazi J, Scherrer D, Ehrlich HJ, Vandekerckhove L. Rutsaert S, et al. J Virus Erad. 2019 Jan 1;5(1):10-22. J Virus Erad. 2019. PMID: 30800421 Free PMC article.

10

Evaluation of HIV-1 reservoir levels as possible markers for virological failure during boosted darunavir monotherapy.

Rutsaert S, De Spiegelaere W, De Clercq L, Vandekerckhove L. Rutsaert S, et al. J Antimicrob Chemother. 2019 Oct 1;74(10):3030-3034. doi: 10.1093/jac/dkz269. J Antimicrob Chemother. 2019. PMID: 31314108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page